Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan R Targan

Showing results (81-90 of 189) with videos related to

Pageof 19
Sort By:
The American Journal of Gastroenterology|December 2, 2004
Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotypeIan D R Arnott, Carol J Landers, Elaine J Nimmo, et al.
Digestive Diseases and Sciences|September 25, 2004
High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot studyWilliam S Mow, Carol J Landers, A Hillary Steinhart, et al.
Gastroenterology|March 23, 2002
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel diseaseMarla C Dubinsky, Huiying Yang, Philip V Hassard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell phenotype and Th1 or T-regulatory 1 cytokine profileKonstantinos A Papadakis, Carol Landers, John Prehn, et al.
European Journal of Immunology|October 20, 2009
Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cellsDavid Q Shih, Lola Y Kwan, Valerie Chavez, et al.
Digestive Diseases and Sciences|October 6, 2015
Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn's ColitisSasha Taleban, Martijn G H Van Oijen, Eric A Vasiliauskas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel diseaseWilliam S Mow, Simon K Lo, Stephan R Targan, et al.
Gastroenterology|June 9, 2005
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's diseaseStephan R Targan, Carol J Landers, Huiying Yang, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytesHon Wai Koon, David Q Shih, Tressia C Hing, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
A blood-based transcriptomic signature stratifies severe Crohn's disease and defines potentially targetable therapeutic pathwaysRivkah Gonsky, Evan Adams, Alka A Potdar, et al.
Pageof 19

Showing results (81-90 of 189) with videos related to

Sort By:
Pageof 19
The American Journal of Gastroenterology|December 2, 2004
Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotypeIan D R Arnott, Carol J Landers, Elaine J Nimmo, et al.
Digestive Diseases and Sciences|September 25, 2004
High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot studyWilliam S Mow, Carol J Landers, A Hillary Steinhart, et al.
Gastroenterology|March 23, 2002
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel diseaseMarla C Dubinsky, Huiying Yang, Philip V Hassard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2003
CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell phenotype and Th1 or T-regulatory 1 cytokine profileKonstantinos A Papadakis, Carol Landers, John Prehn, et al.
European Journal of Immunology|October 20, 2009
Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cellsDavid Q Shih, Lola Y Kwan, Valerie Chavez, et al.
Digestive Diseases and Sciences|October 6, 2015
Colectomy with Permanent End Ileostomy Is More Cost-Effective than Ileal Pouch-Anal Anastomosis for Crohn's ColitisSasha Taleban, Martijn G H Van Oijen, Eric A Vasiliauskas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 16, 2004
Initial experience with wireless capsule enteroscopy in the diagnosis and management of inflammatory bowel diseaseWilliam S Mow, Simon K Lo, Stephan R Targan, et al.
Gastroenterology|June 9, 2005
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's diseaseStephan R Targan, Carol J Landers, Huiying Yang, et al.
Antimicrobial Agents and Chemotherapy|May 1, 2013
Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytesHon Wai Koon, David Q Shih, Tressia C Hing, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
A blood-based transcriptomic signature stratifies severe Crohn's disease and defines potentially targetable therapeutic pathwaysRivkah Gonsky, Evan Adams, Alka A Potdar, et al.
Pageof 19